SCOPUS 정보 검색 플랫폼

Journal of the American College of Cardiology

Volumn 60, Issue 20, 2012, Pages 2072-2073

Fibrates and cardiorenal outcomes

(2) McCullough, Peter A a,c Di Loreto, Michael J b,c

a PROVIDENCE HOSPITAL (United States)

b ST JOHN HOSPITAL AND MEDICAL CENTER (United States)

c St John Providence Health System (United States)

Author keywords

cardiovascular event(s); cardiovascular mortality; chronic kidney disease; fibrates; glomerular filtration; microalbuminuria

Indexed keywords

CHYLOMICRON; FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

CARDIORENAL OUTCOME; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; DYSLIPIDEMIA; ENZYME INDUCTION; GENETIC TRANSCRIPTION; GLOMERULUS FILTRATION; HEART INFARCTION; HUMAN; HYPERTRIGLYCERIDEMIA; KIDNEY BLOOD FLOW; LIPID METABOLISM; LIPOLYSIS; MICROALBUMINURIA; NOTE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RISK BENEFIT ANALYSIS; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84868584916 PISSN: 07351097 EISSN: 15583597 Source Type: Journal
DOI: 10.1016/j.jacc.2012.06.058 Document Type: Editorial

Times cited : (7)

References (12)

1
- 34248589911
- Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) regulatory cascade in cardiac physiology and disease
- B.N. Finck, D.P. Kelly Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) regulatory cascade in cardiac physiology and disease Circulation 115 2007 2540 2548
- (2007) Circulation , vol.115 , pp. 2540-2548
- Finck, B.N.¹ Kelly, D.P.²

2
- 49449100106
- Therapeutic effects of fibrates in postprandial lipemia
- G.D. Kolovou, P.M. Kostakou, K.K. Anagnostopoulou, D.V. Cokkinos Therapeutic effects of fibrates in postprandial lipemia Am J Cardiovasc Drugs 8 2008 243 255
- (2008) Am J Cardiovasc Drugs , vol.8 , pp. 243-255
- Kolovou, G.D.¹ Kostakou, P.M.² Anagnostopoulou, K.K.³ Cokkinos, D.V.⁴

3
- 68949122515
- Regulation of bile acid and cholesterol metabolism by PPARs
- T. Li, J.Y. Chiang Regulation of bile acid and cholesterol metabolism by PPARs PPAR Res 2009 2009 501739
- (2009) PPAR Res , vol.2009 , pp. 501739
- Li, T.¹ Chiang, J.Y.²

4
- 84855557895
- Treatment of hypertriglyceridemia with fibric acid derivatives: Impact on lipid subfractions and translation into a reduction in cardiovascular events
- P.A. McCullough, A.B. Ahmed, M.T. Zughaib, E.D. Glanz, M.J. Di Loreto Treatment of hypertriglyceridemia with fibric acid derivatives: impact on lipid subfractions and translation into a reduction in cardiovascular events Rev Cardiovasc Med 12 2011 173 185
- (2011) Rev Cardiovasc Med , vol.12 , pp. 173-185
- McCullough, P.A.¹ Ahmed, A.B.² Zughaib, M.T.³ Glanz, E.D.⁴ Di Loreto, M.J.⁵

5
- 77952422358
- The effect of PPAR-alpha agonism on apolipoprotein metabolism in humans
- A. Shah, D.J. Rader, J.S. Millar The effect of PPAR-alpha agonism on apolipoprotein metabolism in humans Atherosclerosis 210 2010 35 40
- (2010) Atherosclerosis , vol.210 , pp. 35-40
- Shah, A.¹ Rader, D.J.² Millar, J.S.³

6
- 0037426396
- Relationships between low-density lipoprotein particle size, plasma lipoproteins, and progression of coronary artery disease: The Diabetes Atherosclerosis Intervention Study (DAIS)
- DAIS Group
- J. Vakkilainen, G. Steiner, J.C. Ansquer DAIS Group Relationships between low-density lipoprotein particle size, plasma lipoproteins, and progression of coronary artery disease: the Diabetes Atherosclerosis Intervention Study (DAIS) Circulation 107 2003 1733 1737
- (2003) Circulation , vol.107 , pp. 1733-1737
- Vakkilainen, J.¹ Steiner, G.² Ansquer, J.C.³

7
- 75149128670
- Effects of long-term fenofibrate treatment on markers of renal function in type 2 diabetes: The FIELD Helsinki substudy
- C. Forsblom, A. Hiukka, E.S. Leinonen, J. Sundvall, P.H. Groop, M.R. Taskinen Effects of long-term fenofibrate treatment on markers of renal function in type 2 diabetes: the FIELD Helsinki substudy Diabetes Care 33 2010 215 220
- (2010) Diabetes Care , vol.33 , pp. 215-220
- Forsblom, C.¹ Hiukka, A.² Leinonen, E.S.³ Sundvall, J.⁴ Groop, P.H.⁵ Taskinen, M.R.⁶

8
- 68449092501
- Fibrate therapy and renal function
- D.A. Sica Fibrate therapy and renal function Curr Atheroscler Rep 11 2009 338 342
- (2009) Curr Atheroscler Rep , vol.11 , pp. 338-342
- Sica, D.A.¹

9
- 79954595744
- Fenofibrate, homocysteine and renal function
- C. Foucher, L. Brugère, J.C. Ansquer Fenofibrate, homocysteine and renal function Curr Vasc Pharmacol 8 2010 589 603
- (2010) Curr Vasc Pharmacol , vol.8 , pp. 589-603
- Foucher, C.¹ Brugère, L.² Ansquer, J.C.³

10
- 33745511931
- Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications
- R.M. Touyz, E.L. Schiffrin Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications Vascul Pharmacol 45 2006 19 28
- (2006) Vascul Pharmacol , vol.45 , pp. 19-28
- Touyz, R.M.¹ Schiffrin, E.L.²

11
- 84868533549
- Effects of fibrates in kidney disease: A systematic review and meta-analysis
- M. Jun, B. Zhu, M. Tonelli Effects of fibrates in kidney disease: a systematic review and meta-analysis J Am Coll Cardiol 60 2012 2061 2071
- (2012) J Am Coll Cardiol , vol.60 , pp. 2061-2071
- Jun, M.¹ Zhu, B.² Tonelli, M.³

12
- 84891738297
- Very low density lipoprotein metabolism in patients with chronic kidney disease
- X. Wang, S. Belani, D.W. Coyne Very low density lipoprotein metabolism in patients with chronic kidney disease Cardiorenal Med 2 2012 57 65
- (2012) Cardiorenal Med , vol.2 , pp. 57-65
- Wang, X.¹ Belani, S.² Coyne, D.W.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.